新冠疫情前后感染流行病学特征的新见解
New Insights into the Epidemiological Characteristics of Infection before and after the COVID-19 Pandemic.
作者信息
Wu Qianyue, Pan Xiaozhou, Han Dingding, Ma Zhan, Zhang Hong
机构信息
Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.
Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.
出版信息
Microorganisms. 2024 Oct 5;12(10):2019. doi: 10.3390/microorganisms12102019.
Abstract
(), a prevalent respiratory pathogen affecting children and adolescents, is known to trigger periodic global epidemics. The most recent significant outbreak commenced in the first half of 2023 and reached its peak globally during the autumn and winter months. Considering the worldwide repercussions of the COVID-19 pandemic, it has become increasingly essential to delve into the epidemiological characteristics of both before and after the pandemic. This review aims to provide a comprehensive analysis of the key features of epidemics in the pre-and post-COVID-19 contexts, including but not limited to shifts in the susceptible population, the molecular genotypes of the pathogen, the clinical manifestations, and potential new trends in drug resistance. Additionally, we will introduce the latest advancements in the diagnosis of .
摘要
（）是一种影响儿童和青少年的常见呼吸道病原体，已知会引发周期性的全球流行。最近一次重大疫情于2023年上半年开始，并在秋冬季节达到全球高峰。考虑到新冠疫情的全球影响，深入研究疫情前后的流行病学特征变得越来越重要。本综述旨在全面分析新冠疫情前后该病原体流行的关键特征，包括但不限于易感人群的变化、病原体的分子基因型、临床表现以及耐药性的潜在新趋势。此外，我们还将介绍该病原体诊断方面的最新进展。
相似文献
1
New Insights into the Epidemiological Characteristics of Infection before and after the COVID-19 Pandemic.新冠疫情前后感染流行病学特征的新见解
Microorganisms. 2024 Oct 5;12(10):2019. doi: 10.3390/microorganisms12102019.
2
Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic.中国广州在新冠大流行后出现肺炎支原体感染爆发。
Virol J. 2024 Aug 11;21(1):183. doi: 10.1186/s12985-024-02458-z.
3
Mycoplasma pneumoniae among Chinese Outpatient Children with Mild Respiratory Tract Infections during the Coronavirus Disease 2019 Pandemic.2019 年冠状病毒病大流行期间，中国门诊轻症呼吸道感染患儿中的肺炎支原体。
Microbiol Spectr. 2022 Feb 23;10(1):e0155021. doi: 10.1128/spectrum.01550-21. Epub 2022 Feb 9.
4
Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.中国重庆 COVID-19 大流行限制前后住院儿童肺炎支原体的流行病学特征。
Front Cell Infect Microbiol. 2024 Aug 16;14:1424554. doi: 10.3389/fcimb.2024.1424554. eCollection 2024.
5
The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic.北京儿童在新冠疫情前和期间肺炎支原体感染的流行情况。
Front Cell Infect Microbiol. 2022 Apr 29;12:854505. doi: 10.3389/fcimb.2022.854505. eCollection 2022.
6
Influence of COVID-19 pandemic on the epidemiology of infections among hospitalized children in Henan, China.新型冠状病毒肺炎疫情对中国河南省住院儿童感染性疾病流行病学的影响。
Heliyon. 2023 Nov 10;9(11):e22213. doi: 10.1016/j.heliyon.2023.e22213. eCollection 2023 Nov.
7
Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022.2020-2022 年武汉儿童肺炎支原体肺炎的分子流行病学研究。
BMC Microbiol. 2024 Jan 17;24(1):23. doi: 10.1186/s12866-024-03180-0.
8
Characteristics of the Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends.2019年至2020年韩国疫情特征：大环内酯类耐药性及合并感染趋势
Antibiotics (Basel). 2023 Nov 13;12(11):1623. doi: 10.3390/antibiotics12111623.
9
triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020.触发北京秋冬肺炎疫情：2015 年至 2020 年间的一项多中心、基于人群的流行病学研究。
Emerg Microbes Infect. 2022 Dec;11(1):1508-1517. doi: 10.1080/22221751.2022.2078228.
10
An outbreak of in children after the COVID-19 pandemic, Shanghai, China, 2023.2023年，中国上海，新冠疫情后儿童中的一次[疾病名称缺失]暴发。
Front Microbiol. 2024 Aug 14;15:1427702. doi: 10.3389/fmicb.2024.1427702. eCollection 2024.
引用本文的文献
1
The Clinical Profile of Pediatric Infections in the Context of a New Post-Pandemic Wave.疫情后新一波浪潮背景下儿童感染的临床概况
Microorganisms. 2025 May 17;13(5):1152. doi: 10.3390/microorganisms13051152.
2
Development and validation of an early diagnosis model for severe mycoplasma pneumonia in children based on interpretable machine learning.基于可解释机器学习的儿童重症支原体肺炎早期诊断模型的构建与验证
Respir Res. 2025 May 13;26(1):182. doi: 10.1186/s12931-025-03262-1.
3
A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era.新冠疫情后时代儿童和成人肺炎支原体肺炎的诊断与治疗方法比较
Eur J Clin Microbiol Infect Dis. 2025 Apr 29. doi: 10.1007/s10096-025-05142-4.
4
The Impact of the COVID-19 Pandemic on Pediatric Microbial Resistance Patterns and Abandonment Rates in Western Romania-An Interdisciplinary Study.新冠疫情对罗马尼亚西部儿童微生物耐药模式及抗生素停用率的影响——一项跨学科研究
Antibiotics (Basel). 2025 Apr 16;14(4):411. doi: 10.3390/antibiotics14040411.
5
Impact of the COVID-19 Pandemic on Epidemiological Trends in Pediatric Cervical Abscess-Forming Infections.新冠疫情对小儿颈深部脓肿形成性感染流行病学趋势的影响
Microorganisms. 2025 Jan 17;13(1):190. doi: 10.3390/microorganisms13010190.
本文引用的文献
1
Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of Pneumonia in Children and Adolescents in South Korea.韩国儿童和青少年肺炎的临床表现、大环内酯类耐药性及治疗利用趋势
Microorganisms. 2024 Aug 31;12(9):1806. doi: 10.3390/microorganisms12091806.
2
Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023-2024.2023-2024 年法国马赛大规模肺炎支原体感染爆发。
Emerg Infect Dis. 2024 Jul;30(7):1481-1484. doi: 10.3201/eid3007.240315. Epub 2024 May 30.
3
Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region.亚太地区成人肺炎支原体感染的疾病负担和大环内酯类耐药性。
Int J Antimicrob Agents. 2024 Aug;64(2):107205. doi: 10.1016/j.ijantimicag.2024.107205. Epub 2024 May 14.
4
Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children: A clinical and epidemiological study in 2023 in Wuhan, China.2023 年中国武汉儿童肺炎支原体流行中 A2063G 突变株的优势：一项临床和流行病学研究。
Int J Infect Dis. 2024 Aug;145:107074. doi: 10.1016/j.ijid.2024.107074. Epub 2024 May 9.
5
Epidemic features and megagenomic analysis of childhood post COVID-19 pandemic: a 6-year study in southern China.儿童新冠大流行后(post-COVID-19 pandemic)的流行特征和巨基因组学分析：中国南方的一项为期 6 年的研究。
Emerg Microbes Infect. 2024 Dec;13(1):2353298. doi: 10.1080/22221751.2024.2353298. Epub 2024 Jun 27.
6
A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.儿童普通型与重症肺炎支原体肺炎的对比研究。
BMC Infect Dis. 2024 Apr 26;24(1):449. doi: 10.1186/s12879-024-09340-x.
7
Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China.全基因组测序揭示了中国大陆肺炎支原体的暴发。
Lancet Microbe. 2024 Sep;5(9):100870. doi: 10.1016/S2666-5247(24)00086-7. Epub 2024 Apr 17.
8
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.全球、区域和国家非 COVID-19 下呼吸道感染及病因的发病率、死亡率负担，1990-2021 年：来自 2021 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15.
9
Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Infection: A Descriptive Study.新冠疫情后大环内酯类耐药感染的反弹：一项描述性研究
Antibiotics (Basel). 2024 Mar 15;13(3):262. doi: 10.3390/antibiotics13030262.
10
Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland.瑞士南部成人中重症肺炎支原体肺炎意外增加。
Clin Microbiol Infect. 2024 Jul;30(7):953-954. doi: 10.1016/j.cmi.2024.03.008. Epub 2024 Mar 9.
Zotero 插件